BS EN 14476:2025 - Chemical Disinfectants and Antiseptics

Introducing the BS EN 14476:2025, a comprehensive standard that sets the benchmark for evaluating the virucidal activity of chemical disinfectants and antiseptics in the medical area. This essential document is a must-have for professionals in the healthcare and sanitation industries, providing a detailed methodology for assessing the effectiveness of disinfectants against viruses.

Overview

The BS EN 14476:2025 standard is a critical tool for ensuring the safety and efficacy of disinfectants used in medical settings. Released on October 1, 2025, this standard outlines the quantitative suspension test method, which is a pivotal part of the Phase 2/Step 1 evaluation process. This test is designed to rigorously assess the virucidal activity of chemical agents, ensuring they meet the necessary requirements to be deemed effective in combating viral pathogens.

Key Features

• Standard Number: BS EN 14476:2025
• Pages: 54
• ISBN: 978 0 539 30594 4
• Status: Standard

Why Choose BS EN 14476:2025?

This standard is indispensable for manufacturers, laboratories, and healthcare facilities that are committed to maintaining the highest levels of hygiene and safety. By adhering to the guidelines set forth in BS EN 14476:2025, organizations can ensure that their disinfectants are not only compliant with international standards but also effective in real-world applications.

Comprehensive Testing Methodology

The quantitative suspension test detailed in this standard provides a robust framework for evaluating the virucidal activity of disinfectants. This method is designed to simulate real-life conditions, offering a reliable measure of a product's effectiveness against a wide range of viruses. By following this standardized approach, users can confidently assess the performance of their disinfectants, ensuring they meet the necessary criteria for use in medical environments.

Ensuring Safety and Compliance

Compliance with BS EN 14476:2025 is crucial for any organization involved in the production or use of chemical disinfectants and antiseptics. This standard not only helps ensure the safety of patients and healthcare workers but also supports regulatory compliance, reducing the risk of legal and financial repercussions. By implementing the guidelines outlined in this document, organizations can demonstrate their commitment to maintaining the highest standards of hygiene and safety.

Who Should Use This Standard?

The BS EN 14476:2025 standard is designed for a wide range of professionals and organizations, including:

• Manufacturers of chemical disinfectants and antiseptics
• Quality assurance and regulatory compliance teams
• Healthcare facilities and hospitals
• Laboratories conducting virucidal activity testing
• Public health organizations and agencies

Conclusion

In an era where hygiene and safety are more critical than ever, the BS EN 14476:2025 standard provides the necessary tools and guidelines to ensure the effectiveness of chemical disinfectants and antiseptics. By adopting this standard, organizations can enhance their infection control measures, protect public health, and maintain compliance with international regulations.

Invest in the BS EN 14476:2025 standard today and take a proactive step towards ensuring the safety and efficacy of your disinfectant products. With its comprehensive methodology and rigorous testing requirements, this standard is an invaluable resource for anyone involved in the production, testing, or use of chemical disinfectants and antiseptics in the medical area.

BS EN 14476:2025

This standard BS EN 14476:2025 Chemical disinfectants and antiseptics. Quantitative suspension test for the evaluation of virucidal activity in the medical area. Test method and requirements (Phase 2/Step 1) is classified in these ICS categories:

• 11.080.20 Disinfectants and antiseptics

TThis document specifies a test method and the minimum requirements for virucidal activity of chemical disinfectant and antiseptic products that form a homogeneous physically stable preparation when diluted with hard water - or in the case of ready-to-use products, i.e, products that are not diluted when applied, - with water. Ready-to-use-products can only be tested at a concentration up to 80 % (97 %, with a modified method for special cases) as some dilution is always produced by adding the test organisms and interfering substance. This document applies to products that are used in the medical area in the fields of hygienic handrub, hygienic handwash, instrument disinfection by immersion, surface disinfection by wiping, spraying, flooding or other means and textile disinfection. This document applies to areas and situations where disinfection is medically indicated. Such indications occur in patient care, for example: - in hospitals, in community medical facilities, and in dental institutions; - in clinics of schools, of kindergartens, and of nursing homes; and can occur in the workplace and in the home. It can also include services such as laundries and kitchens supplying products directly for the patient. NOTE 1 The method described is intended to determine the activity of commercial formulations or active substances under the conditions in which they are used. NOTE 2 This method corresponds to a phase 2, step 1 test. NOTE 3 EN 14885 specifies in detail the relationship of the various tests to one another and to "use recommendations".